_logo_big.png){kind=logo}
Toronto, Canada, October 23, 2023 – Justera Health Ltd. (CSE: VTAL, OTCQB: SCRSF) (“Justera”or the “Company”) is actively evaluating the possibility of resuming its COVID-19 testing operations, driven by a surge in interest from the film and production industries.
As COVID-19 cases continue to surge, the film and production sector has exhibited an increasing demand for testing solutions to ensure the safety of their workforce.
The Public Health Agency of Canada reports that COVID-19 hospitalizations are on the rise across Canada as a wave of infections sweeps the population with COVID-19 hospitalizations reaching numbers not seen since last winter. (Source: https://www.ctvnews.ca/health/coronavirus/covid-19-hospitalizations-reach-numbers-not-seen-since-last-winter-1.6605491)
“The Company's past success in COVID-19 testing and infectious disease management positions it as a valuable partner in ensuring the safe resumption of production activities. We are actively monitoring the COVID-19 testing policies for the film and production industry and will update the market on any developments”, said Edward Park, Chief Executive Officer of the Company.
About Justera
Established in 2020, Justera Health Ltd. is a Canadian Company focused on health and wellness. Through its services, innovative products, strategic partnerships, Justera empowers individuals to prioritize their well-being. With four subsidiaries, it offers personalized healthcare services and solutions, such as IV Vitamin Therapy, premium nutritional supplements through its Naturevan Nutrition brand, a full 360-degree wellness and spa experience through Juillet Wellness that provides registered massage therapy, acupuncture, and new retail stores in Vancouver. Justera’s mission is to enhance Canadians overall well-being with diverse solutions catering to individual needs.
For additional information on Justera and other corporate information, please visit the Company's website at www.justerahealth.com
For more information about the Company, please refer to the Company's profile on SEDAR+ at www.sedarplus.com.
Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
For further information:
Investor Relations & Communications
Priya Monique Atwal, Director of Communications Tel: (416) 901-5611 x 204 Email: priya@justerahealth.com
Edward Park, Chief Executive Officer Tel: (416) 901-5611 x 203 Email: epark@justerahealth.com
Forward-Looking Statements:
Certain statements contained in this news release may constitute forward-looking information, including statements relating to the future development of Justera's business. Forward-looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forward-looking information involves known and unknown risks, uncertainties, and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. The actual results of Justera could differ materially from those anticipated in this forward-looking information as a result of regulatory decisions, competitive factors in the industries in which Justera operates, prevailing economic conditions, changes to Justera's strategic growth plans, and other factors, many of which are beyond the control of Justera. Management of Justera believes that the expectations reflected in the forward-looking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking information should not be unduly relied upon. Any forward‐looking information contained in this news release represents Justera's expectations as of the date hereof and is subject to change after such date. Justera disclaims any intention or obligation to update or revise any forward‐looking information whether as a result of new information, future events, or otherwise, except as required by applicable securities legislation.
###